Risedronate Sodium
Who holds supplier records for Risedronate Sodium? 11 organisations hold a current record for Risedronate Sodium: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (9), Netherlands (1) and Poland (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Risedronate Sodium: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/risedronate-sodium
Reading the evidence
- 11 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
9 of the 11 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 7 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (11)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Risedronate Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 20398 · latest filing Apr 2007
- ALCHYMARS ICM SM PRIVATE LTDIndiaActive DMF 24591 · latest filing Jan 2011
- Macleods Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 23738 · latest filing Apr 2010
- ORBION PHARMACEUTICALS PRIVATE LTDIndia Company GMP cert on recordActive DMF 25768 · latest filing Mar 2012
- TAPI NL BVNetherlandsActive DMF 16604 · latest filing May 2003
- IndiaCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
- IndiaCEP
- SYNTHIMED LABS PRIVATE LIMITEDIndiaCEP Company GMP cert on record
- PolandCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (7)
Certificates of Suitability on the EDQM register for Risedronate Sodium, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 9 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdanski | PL | CEP 2013-126 - Rev 03 Risedronate sodium 2.5-hydrate, Standard and milled | Jul 2026 | Inspected Jul 2026 Poland |
| JUBILANT BIOSYS LIMITED Nanjangud | IN | CEP 2014-010 - Rev 02 Risedronate sodium 2.5-hydrate | Oct 2025 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District | IN | CEP 2013-009 - Rev 02 Risedronate sodium 2.5-hydrate | Oct 2025 | — |
| SYNTHIMED LABS PRIVATE LIMITED Derabassi | IN | CEP 2014-245 - Rev 01 Risedronate sodium 2.5-hydrate | Aug 2024 | Inspected Aug 2026 Slovenia |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2013-120 - Rev 02 Risedronate sodium 2.5-hydrate | Jan 2024 | — |
| FLEMING LABORATORIES LIMITED Hyderabad | IN | R0-CEP 2021-014 - Rev 00 Risedronate sodium 2.5-hydrate | Jan 2023 | — |
| CIPLA LIMITED Mumbai | IN | R1-CEP 2014-130 - Rev 00 Risedronate sodium 2.5-hydrate | Apr 2020 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (1)
Organisations whose Type II DMFs for Risedronate Sodium are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- India · Inactive DMF 18807 · filed Sept 2005
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Risedronate Sodium is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget's disease of bone. It works by inhibiting bone resorption and modifying the bone turnover cycle.
Chemical identity
- IUPAC name
- sodium hydroxy-(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphinate
- Canonical SMILES
- C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)[O-].[Na+]
- InChIKey
- DRFDPXKCEWYIAW-UHFFFAOYSA-M
- Synonyms
- Actonel API, ne-58095 anhydrous, nsc-722598, nsc-759280, risedronate monosodium, risedronate sodium anhydrous, risedronic acid monosodium salt
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Bisphosphonate
- Chemical structure
- Diphosphonates
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Risedronate Sodium?
11 organisations hold an active US FDA Type II Drug Master File or a CEP for Risedronate Sodium: MATRIX PHARMACORP PRIVATE LTD (India), ALCHYMARS ICM SM PRIVATE LTD (India), Macleods Pharmaceuticals Ltd. (India), ORBION PHARMACEUTICALS PRIVATE LTD (India), TAPI NL BV (Netherlands), APITORIA PHARMA PRIVATE LTD (India), Cipla Limited (India) and FLEMING LABORATORIES LTD (India), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Risedronate Sodium Drug Master Files are active?
MATRIX PHARMACORP PRIVATE LTD (DMF 20398), ALCHYMARS ICM SM PRIVATE LTD (DMF 24591), Macleods Pharmaceuticals Ltd. (DMF 23738), ORBION PHARMACEUTICALS PRIVATE LTD (DMF 25768) and TAPI NL BV (DMF 16604). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Risedronate Sodium records mean?
1 organisation has only inactive Type II DMFs for Risedronate Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Risedronate Sodium have a European Certificate of Suitability?
Yes. 7 organisations hold a valid CEP for Risedronate Sodium on the EDQM register, including ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdanski (PL), JUBILANT BIOSYS LIMITED Nanjangud (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), SYNTHIMED LABS PRIVATE LIMITED Derabassi (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and FLEMING LABORATORIES LIMITED Hyderabad (IN) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Risedronate Sodium supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Risedronate Sodium?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.